The recognition that T cell growth factor (TCGF) can maintain T cells in long-term culture offers the opportunity of expanding populations of monoclonal antigen-specific T lymphocytes with helper, suppressor or cytotoxic activity (Fathman & Fitch, 1982). The application of this technology in the generation of tumour reactive T cells for the analysis of tumour antigen recognition and their therapeutic potential in the management of malignant disease has evoked much investigation. Indeed, human T cell lines reactive against solid tumours (Vanky et al., 1982; Kedar et al., 1983) and tumour cell lines (Zarling & Bach, 1979; Mitsuya et al., 1983) It is interesting that analysis of the general pattern of anti-tumour specificity revealed that all the oligoclonal T cell lines responded to the autologous tumour cell extract; however with more detailed investigation, distinct patterns of reactivity could be observed (Table I) . Firstly, there were those lines (13.4, 42.4 and 42.5) that proliferated in The
The recognition that T cell growth factor (TCGF) can maintain T cells in long-term culture offers the opportunity of expanding populations of monoclonal antigen-specific T lymphocytes with helper, suppressor or cytotoxic activity (Fathman & Fitch, 1982) . The application of this technology in the generation of tumour reactive T cells for the analysis of tumour antigen recognition and their therapeutic potential in the management of malignant disease has evoked much investigation. Indeed, human T cell lines reactive against solid tumours (Vanky et al., 1982; Kedar et al., 1983) and tumour cell lines (Zarling & Bach, 1979; Mitsuya et al., 1983) response to all the cell extracts used including autologous T cells. There are several explanations for this pattern of specificity. The lines may recognize an activation antigen such as the transferrin receptor present on both T lymphocytes and tumour cells. Alternatively, they are non-specific and are merely activated by the culture conditions or by "back stimulation" resulting in TCGF release from the interaction of antigen and PBL (Lamb et al., 1982a (Vose & Bonnard, 1982b) . However, the analysis reported here demonstrates a more diverse repertoire of antigen specificities in that both cross reactive and tumour specific T cell lines were identified. This may be explained partly by the fact that in the present study after only 6 days primary in vitro culture in the absence of TCGF oligoclonal lines were isolated. In addition the manner in which the antigen is presented either on the tumour cell surface or as a soluble extract may influence the repertoire of T cells selected, as has been reported for example, for influenza virus immune T cells (Lamb et al., 1982b) . The heterogeneity of the antigen specificity observed in the oligoclonal lines induced with autologous tumour extract raises the possibility that multiple determinants might be critical for T cell tumour antigen recognition. This stresses the necessity for cloning anti-tumour responsive cells early and analysing the specificity and interaction of these cells in the overall immune response.
As a cautionary note, we were unable to maintain these lines in culture beyond 50 days similar to other laboratories. This perhaps was largely due to being unable to acquire an adequate number of autologous PBL for maintaining the lines and the failure to culture the tumour cells in vitro. However, despite such problems this approach may allow the identification of tumour associated determinants that appear to be unique or cross reactive. It is this latter category of determinants that offer the widest range of potential in tumour immunology.
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